Table 2.
Baseline characteristics of the study population *.
| Dog | Study Arm | Dog Breed | Age (Years) | Weight (kg) | Sex (F/M) | Neuter Status (Y/N) | Medication |
|---|---|---|---|---|---|---|---|
| 1 | MCT | Boxer–Pointer Mix | 15 | 27 | F | Y | - |
| 3 | Pug | 3 | 12 | M | N | - | |
| 4 | Sheltie–Jack Russel Mix | 14 | 14 | F | Y | - | |
| 7 | Labrador | 2 | 14 | F | N | - | |
| 10 | Dwarf Schnauzer | 10 | 8 | F | Y | - | |
| 13 | Flat-Coated Retriever | 3 | 32 | M | N | - | |
| 14 | Labradoodle | 1 | 30 | M | N | - | |
| 15 | Labrador | 6 | 23 | F | Y | - | |
| 16 | Sheltie–Jack Russel Mix | 14 | 12 | F | Y | Caniphedrine | |
| 18 | Parson Russel Terrier Mix | 7 | 6 | F | Y | Omega 3 fatty acids | |
| 2 | Control | German-Shepard–Husky Mix | 8 | 28 | F | Y | - |
| 5 | Shetland Sheepdog | 3 | 9 | F | Y | - | |
| 6 | German Shephard | 10 | 42 | M | Y | Cimicoxib | |
| 8 | Labrador Mix | 9 | 10 | F | Y | - | |
| 9 | Border Collie | 7 | 23 | M | Y | - | |
| 11 | Chihuahua | 5 | 2 | F | N | - | |
| 17 | Golden Retriever | 13 | 30 | M | Y | - | |
| 19 | Pug | 9 | 9 | M | N | Antiacida | |
| 20 | Australian Shephard | 9 | 22 | F | N | - |
* Dog number 12 was excluded from the study due to owner non-compliance.